Separation anxiety disorder in children and adolescents: Epidemiology, diagnosis and management

CNS Drugs

Volumn 15, Issue 2, 2001, Pages 93-104

  Masi, G ^a   Mucci, M ^a   Millepiedi, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; AGORAPHOBIA; BEHAVIOR THERAPY; CARDIOTOXICITY; CHILD; COGNITIVE THERAPY; COMORBIDITY; DRUG CHOICE; DRUG DEPENDENCE; FAMILY THERAPY; FATIGUE; HUMAN; OUTCOMES RESEARCH; PANIC; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SEDATION; SEPARATION ANXIETY; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 0035092437     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115020-00002     Document Type: Review

References (94)

1. Attachment and separation in young children
2. DSM-III-R anxiety disorders in children: Sociodemographic and clinical characteristics
3. Attachment in mothers with anxiety disorders and their children
4. The circumventricular organs form a potential neural pathway for lactate sensitivity: Implications for panic disorder
5. Childhood derivatives of high and low reactivity in infancy
6. Childhood anxiety: Integrating developmental psychopathology and affective neuroscience
7. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC 2.3): Description, acceptability, prevalence rates, and performance in the MACA study
8. The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents
9. The great smoky mountains study of youth: Goals, design, methods, and the prevalence of DSM-III-R disorders
10. The prevalence of overanxious disorder and separation anxiety disorder: Results from the Ontario Child Health Study
11. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population
12. DSM-III disorders in a large sample of adolescents
13. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures
14. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students
15. Quebec Child Mental Health Survey: Prevalence of DSM-III-R mental health disorders
16. Psychological disorders and their correlates in an Australian community sample of preadolescent children
17. Separation anxiety and school phobia: A comparison using DSM III criteria
18. A longitudinal analysis of selected risk factors for childhood psychopathology
19. Expression of separation anxiety disorder: The role of age and gender
20. Comorbidity among childhood anxiety disorders
21. Symptomatology and comorbidity of generalized anxiety disorder in children and adolescents
22. A comparison of inpatient and outpatient school refusers
23. Separation anxiety disorder and panic disorder
24. A three-generational presentation of separation anxiety in childhood with agoraphobia in adulthood
25. Teenage school refusers grow-up: A follow-up study of 168 subjects, ten years on average after in-patient treatment
26. School phobia with separation anxiety disorder: A comparative 20- to 29-year follow-up study of 35 school refusers
27. Adults who feared school: Is early separation anxiety specific to the pathogenesis of panic disorder?
28. Is early separation anxiety a specific precursor of panic disorder-agoraphobia? A community study
29. Reported early separation anxiety symptoms in patients with panic and generalized anxiety disorders
30. Subpopulations of early separation anxiety: Relevance to risk of adult anxiety disorder
31. Psychiatrically referred adolescents with panic attacks: Presenting symptoms, stressors and comorbidity
32. Panic disorder and agoraphobia in consecutively referred children and adolescents
33. Depressive comorbidity in children and adolescents with generalized anxiety disorder
34. Fear, anxiety and perceived control in children of agoraphobic parents
35. The risk for early adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders
36. School refusal, truancy, and adult neurotic illness
37. Childhood separation anxiety and adult-onset panic disorders
38. On the longitudinal course of panic disorder: Developmental history and predictors of phobic complications
39. Childhood separation anxiety disorder in patients with adult anxiety disorder
40. Is early separation anxiety a risk factor for adult panic disorder? A critical reviev
41. Age of onset of panic disorder: Influence of familial liability to the disease and of childhood separation anxiety disorder
42. Is there an adult form of separation anxiety disorder? A brief clinical report
43. Is lifetime separation anxiety a manifestation of a panic spectrum?
44. Childhood temperament
45. Anxiety and depressive disorder in fathers and mothers of anxious school-refusing children
46. A community study of anxiety in children and adolescents
47. Panic disorder in clinically referred children and adolescents
48. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study
49. The multidimensional anxiety scale for children (MASC): Factor structure, reliability, and validity
50. The assessment of anxiety states by rating
51. Treatment of child phobias
52. The behavioral treatment of school refusal - A comparative study
53. Treating anxiety disorders in children: Results of a randomized clinical trial
54. Cognitive-behavioral treatment of school-refusing children: A controlled evaluation
55. Cognitive-behavioral treatment of school phobia
56. Cognitive-behavioral group treatments in childhood anxiety disorders: The role of parental involvement
57. Psychoanalysis and psychodynamic psychotherapy
58. School phobia: Pattern of family functioning
59. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders
60. Controlled imipramine treatment of school phobia
61. Imipramine treatment of children with separation anxiety disorder
62. School phobia: A therapeutic trial with clomipramine and short-term outcome
63. Comparative studies of pharmacotherapy for school refusal
64. Imipramine in adolescent major depression: Plasma levels and clinical response
65. Imipramine and cognitive therapy for children and adolescents with school phobia
66. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal
67. Electrocardiographic changes during desimipramine and clomipramine treatment in children and adolescents
68. Fluoxetine in anxiety disorders
69. Fluoxetine for childhood anxiety disorders
70. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
71. A multisite double blind placebo-controlled trial of fluvoxamine for children and adolescents with anxiety disorders
72. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorder
73. Clonazepam in childhood anxiety disorders
74. The pharmacotherapy of anxiety disorders in children and adolescents
75. Case study: Use of buspirone in an adolescent with overanxious disorder
76. Pharmacotherapy of childhood anxiety disorders
77. Buspirone therapy of mixed anxiety disorders in childhood and adolescents: A pilot study
78. Anxiolytics for children and adolescents: Traditional and new drugs
79. Tourette syndrome, pimozide, and school phobia: The neuroleptic separation anxiety syndrome
80. School avoidance and school phobia triggered by haloperidol in patients with Tourette's disorder
81. Separation anxiety in children and adolescents treated with risperidone
82. Mirtazapine: Other indications
83. Overview of antidepressants currently used to treat anxiety disorders
84. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder
85. The evolution and reconciliation of taxonomic strategies for school refusal behavior
86. Pharmacologic treatment for children and adolescents with anxiety disorders